Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study

BACKGROUND: Low-molecular-weight heparin (LMWH) is the drug of choice to prevent venous thrombosis in pregnancy, but the optimal dose for prevention while avoiding bleeding is unclear. This study investigated whether therapeutic doses of LMWH increase the incidence of postpartum haemorrhage (PPH) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Roshani, Sara, Cohn, Danny M, Stehouwer, Alexander C, Wolf, Hans, van der Post, Joris A M, Büller, Harry R, Kamphuisen, Pieter W, Middeldorp, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Haematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221289/
https://www.ncbi.nlm.nih.gov/pubmed/22102641
http://dx.doi.org/10.1136/bmjopen-2011-000257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221289/
https://www.ncbi.nlm.nih.gov/pubmed/22102641
http://dx.doi.org/10.1136/bmjopen-2011-000257

Ejemplares similares